Dual Time Point PET Imaging in Lymphoma

Hodgkin's or Non-Hodgkin's Lymphoma Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT00297557
• Other study ID #: CCR2733
• Status: Not yet recruiting
• Phase: N/A
• First received: February 27, 2006
• Last updated: October 10, 2006

Study information

• Verified date: January 2006
• Source: Royal Marsden NHS Foundation Trust
• Contact: Dr Gary Cook
• Phone: 020 8661 3921
• Is FDA regulated: No
• Health authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency
• Study type: Observational

Clinical Trial Summary

Comparison of single time point with dual time point PET imaging in the accuracy of diagnosing active lymphoma. Biopsy results or clinical/radiological progression will be used in conjunction with the PET data.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 0
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Age 16 and above Diagnosis of Hodgkin's or Non-Hodgkin's lymphoma PET scan scheduled as part of management

Exclusion Criteria:

• Pregnant or lactating Diabetes mellitus

Study Design

Observational Model: Defined Population, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Hodgkin's or Non-Hodgkin's Lymphoma
• Lymphoma, Non-Hodgkin

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Royal Marsden NHS Foundation Trust